No obvious phenotypes are seen when benScer\UAS.cUa is expressed under the control of Scer\GAL4ptc-559.1.
Expression of benScer\UAS.cUa both pre- and post-synaptically under the control of Scer\GAL4OK307 does not affect synapse physiology.
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has visible phenotype, suppressible by Scer\GAL4ptc-559.1/Traf6RNAi.UAS
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has visible phenotype, suppressible by Scer\GAL4ptc-559.1/Tak1NIG.1388R
benUAS.cUa, Uev1AUAS.cMa, Scer\GAL4GMR.PF is an enhancer of increased cell death phenotype of Scer\GAL4GMR.PF, nopoUAS.cUa
benUAS.cUa/Scer\GAL4GMR.PF is a non-enhancer of increased cell death phenotype of Scer\GAL4GMR.PF, nopoUAS.cUa
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has visible phenotype
Scer\GAL4ptc-559.1, Traf6RNAi.UAS, Uev1AUAS.cMa, benUAS.cUa has visible phenotype
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has anterior crossvein phenotype, suppressible by Scer\GAL4ptc-559.1/Traf6RNAi.UAS
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has anterior crossvein phenotype, suppressible by Scer\GAL4ptc-559.1/Tak1NIG.1388R
benUAS.cUa, Uev1AUAS.cMa, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, nopoUAS.cUa
benUAS.cUa/Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Scer\GAL4GMR.PF, nopoUAS.cUa
Scer\GAL4ptc-559.1, Uev1AUAS.cMa, benUAS.cUa has anterior crossvein phenotype
Scer\GAL4ptc-559.1, Traf6RNAi.UAS, Uev1AUAS.cMa, benUAS.cUa has eye phenotype
Co-expression of Uev1AScer\UAS.cMa and benScer\UAS.cUa under the control of Scer\GAL4ptc-559.1 results in loss of the anterior cross vein.
Expression of Traf6dsRNA.Scer\UAS suppresses the anterior crossvein loss seen when Uev1AScer\UAS.cMa and benScer\UAS.cUa are expressed under the control of Scer\GAL4ptc-559.1.
Expression of Tak1NIG.1388R suppresses the anterior crossvein loss seen when Uev1AScer\UAS.cMa and benScer\UAS.cUa are expressed under the control of Scer\GAL4ptc-559.1.
Co-expression of Uev1AScer\UAS.cMa and benScer\UAS.cUa in the eye under the control of Scer\GAL4GMR.PF does not results in any significant phenotype.
Co-expression of Uev1AScer\UAS.cMa, benScer\UAS.cUa and Traf6dsRNA.Scer\UAS under the control of Scer\GAL4GMR.PF results in rough eye with fused ommatidia.
Co-expression of benScer\UAS.cUa does not enhance the small, rough eye phenotype found upon expression of nopoScer\UAS.cUa under the control of Scer\GAL4GMR.PF.
Co-expression of Uev1AScer\UAS.cMa and benScer\UAS.cUa significantly enhances the Scer\GAL4GMR.PF->nopoScer\UAS.cUa small rough eye phenotype.
Scer\GAL4c17/benUAS.cUa rescues ben1
benUAS.cUa/Scer\GAL4c42.2 fails to rescue ben1
Scer\GAL4shakB.lethal.4.1/benUAS.cUa fails to rescue ben1
Expression of benScer\UAS.cUa under the control of Scer\GAL4OK307 rescues the ben1 physiological and anatomical phenotypes.
Expression of benScer\UAS.cUa under the control of Scer\GAL4c17 rescues the ben1 physiological and anatomical phenotypes on 83% of flies. This increases to 91% when two benScer\UAS.cUa transgenes are used.
Pre-synaptic expression of benScer\UAS.cUa under the control of Scer\GAL4c42.2, which turns on expression in the later half of pupal development when the giant fiber would be undergoing additional growth after having made its synapse in wild-type specimens, fails to rescue the ben1 physiological and anatomical phenotypes.
Expression of benScer\UAS.cUa under the control of the postsynaptic Scer\GAL4shakB.lethal.4.1 driver, fails to rescue the ben1 mutant phenotype.